Western blotting analyses demonstrated that downregulation of Akt2 facilitated a CDDP-induced decrease in mitochondrial AIF content and an increase in nuclear AIF level, and sensitised chemoresistant ovarian cancer cells to CDDP-induced apoptosis (Figure 4B). The gene discussed is AKT2; the disease is ovarian carcinoma.